中国在癌症治疗中取得了医学性α同位素生产的突破. China achieves breakthrough in medical alpha isotope production for cancer treatment.

中国在生产用于癌症治疗的医疗α同位素方面取得了突破,使用中国缩中子源实现了三种关键同位体的大规模生产. China has achieved a breakthrough in producing medical alpha isotopes for cancer treatment, enabling mass production of three key isotopes using the China Spallation Neutron Source. 这种新方法减少了对进口的依赖,降低成本,预计到2031年每年的产量将能够治疗近100万名患者. This new method reduces reliance on imports and lowers costs, with an expected annual output capable of treating nearly one million patients by 2031. 一个专门的生产线正在建设中,以加速从研究向临床使用的过渡. A dedicated production line is under construction to accelerate the transition from research to clinical use.